Versant Capital Management »

Kalvista Pharmaceuticals shares owned by Versant Capital Management

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Kalvista Pharmaceuticals

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.00114051,405.514061,406.51407165165.5166166.5167
Value ($)Share countHistorical KALV position of Versant Capital Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.4k 166 8.47

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Vanguard Emerging Markets Government Bond Etf Etf (VWOB)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Microsoft Stock (MSFT)
Ishares S&p Global Energy Etf (IXC)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Vaneck Gold Miners Etf Etf (GDX)
Vanguard Total Stk Mkt Etf (VTI)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Exxon Mobil Corp Stock (XOM)
Apple Stock (AAPL)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Spdr Gold Minishares Trust Etf (GLDM)

View all positions for Versant Capital Management

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Suvretta Capital Management
Tang Capital Management
Frazier Life Sciences Management
Vestal Point Capital
Capital World Investors
BlackRock
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Boxer Capital Management
State Street Corporation
Octagon Capital Advisors
Woodline Partners
Emerald Advisers
Geode Capital Management

View all funds holding Kalvista Pharmaceuticals